for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Supreme Cannabis Company Inc

FIRE.TO

Latest Trade

0.29CAD

Change

-0.01(-1.72%)

Volume

8,387,837

Today's Range

0.28

 - 

0.30

52 Week Range

0.12

 - 

0.60

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
0.29
Open
0.30
Volume
8,387,837
3M AVG Volume
236.88
Today's High
0.30
Today's Low
0.28
52 Week High
0.60
52 Week Low
0.12
Shares Out (MIL)
712.97
Market Cap (MIL)
203.20
Forward P/E
57.00
Dividend (Yield %)
--

Next Event

Q3 2021 Supreme Cannabis Company Inc Earnings Release

Latest Developments

More

Supreme Cannabis Announces Financial Results For Q2 2021

Supreme Cannabis Prices $20 Million Overnight Marketed Public Offering

Supreme Cannabis Announces Financial Results For Q1 2021

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Supreme Cannabis Company Inc

Supreme Cannabis Company Inc, formerly Supreme Pharmaceuticals Inc, is a Canada-based company. The Company is focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company's subsidiary is 8528934 Canada Ltd., doing business as 7 ACRES, a licensed producer of medical cannabis. 8528934 Canada Ltd. cultivates medical cannabis at its approximately seven acres (over 342,000 square feet) hybrid greenhouse (the Hybrid Greenhouse) facility in Kincardine, Ontario.

Industry

Biotechnology & Drugs

Contact Info

178R Ossington Ave

TORONTO, ON

M6J 2Z7

Canada

+1.416.6307272

https://www.supreme.ca

Executive Leadership

Michael John La Brier

Independent Chairman of the Board

Beena Goldenberg

President, Chief Executive Officer, Director

Nikhil Handa

Chief Financial Officer

John Griese

Chief Operating Officer

Jeff Adams

Executive Vice President- Business Development

Key Stats

2.75 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, CAD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.1K
EPS (CAD)

2018

-0.040

2019

-0.050

2020

-0.400

2021(E)

0.005
Price To Earnings (TTM)
--
Price To Sales (TTM)
4.11
Price To Book (MRQ)
0.79
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
42.64
LT Debt To Equity (MRQ)
39.00
Return on Investment (TTM)
-25.88
Return on Equity (TTM)
-24.09

Latest News

Latest News

BRIEF-Supreme Cannabis Announces Change To Board Of Directors

* SUPREME CANNABIS ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS

BRIEF-Supreme Cannabis Announces Q3 2020 Financial Results

* SUPREME CANNABIS ANNOUNCES Q3 2020 FINANCIAL RESULTS Source text for Eikon: Further company coverage:

BRIEF-Supreme Cannabis Company Inc - QTRLY Net Loss C$72.3 Million Versus C$7.1 Million

* SUPREME CANNABIS COMPANY INC - NET REVENUE DECREASED MARGINALLY YEAR-OVER-YEAR FROM $10.0 MILLION IN Q3 2019 TO $9.7 MILLION IN Q3 2020

BRIEF-Supreme Cannabis Appoints Beena Goldenberg As President And CEO

* SUPREME CANNABIS APPOINTS BEENA GOLDENBERG AS PRESIDENT AND CEO

BRIEF-Supreme Cannabis Announces At-The-Market Equity Program

* SUPREME CANNABIS COMPANY INC - TO ISSUE AND SELL UP TO C$9.8 MILLION OF COMMON SHARES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Supreme Cannabis Company Completes First International Cannabis Shipment From Canada Into Israel

* COMPLETES FIRST INTERNATIONAL CANNABIS SHIPMENT FROM CANADA INTO ISRAEL Source text for Eikon: Further company coverage:

BRIEF-Supreme Cannabis Announces Q2 Loss Per Share $0.05

* SUPREME CANNABIS ANNOUNCES Q2 2020 FINANCIAL RESULTS AND UPDATED PLAN FOR ACCELERATED REVENUE GROWTH

BRIEF-Supreme Cannabis Says Recreational Sales In Q2 2020 Reached $5.7 Million

* SUPREME CANNABIS ANNOUNCES Q2 2020 FINANCIAL RESULTS AND UPDATED PLAN FOR ACCELERATED REVENUE GROWTH

BRIEF-Supreme Cannabis Company Says Corporate Positions Decreased By About 33%

* SUPREME CANNABIS COMPANY INC - CORPORATE POSITIONS DECREASED BY APPROXIMATELY 33% AND OPERATIONAL POSITIONS DECREASED BY APPROXIMATELY 13%

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up